Filing Flows › RXO (RXO) › Q3 2026 › vs Q2 2026
RXO (RXO) Q3 2026 vs Q2 2026 (quarter over quarter)
RXO's revenue rose $97.0M (+5%) from $1.8B in Q2 2026 to $1.9B in Q3 2026. Operating margin 0.9% against 0.1% (+0.9 pts).
RXO, Q3 2026: revenue $1.9B (+32% year over year), operating margin 0.9%, net earnings $3.0M, operating cash flow $25.0M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Operating margin | 0.9% | 0.1% | +0.9 pts |
| Net margin | 0.2% | -0.5% | +0.7 pts |
| Free cash flow margin | 0.6% | -2.9% | +3.6 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $1.9B | $1.8B | $97.0M | +5% |
| Operating profit | $17.0M | $1.0M | $16.0M | 17× |
| Costs & expenses | $1.9B | $1.8B | $81.0M | +5% |
| Pre-tax earnings | $6.0M | −$8.0M | $14.0M | — |
| Other expense, net | $11.0M | $9.0M | $2.0M | +22% |
| Cost of revenue | $1.5B | $1.5B | $66.0M | +4% |
| SG&A | $223M | $211M | $12.0M | +6% |
| Other operating costs | $93.0M | $90.0M | $3.0M | +3% |
| Net earnings | $3.0M | −$9.0M | $12.0M | — |
| Income tax | $3.0M | $1.0M | $2.0M | +200% |
| Operating cash sources | $38.0M | $24.0M | $14.0M | +58% |
| Depreciation & amortization | $28.0M | $26.0M | $2.0M | +8% |
| Share-based compensation | $7.0M | $7.0M | $0 | 0% |
| Working capital & other | $13.0M | $64.0M | −$51.0M | -80% |
| Operating cash flow | $25.0M | −$40.0M | $65.0M | — |
| Free cash flow (OCF − capex) | $12.0M | −$52.0M | $64.0M | — |
| Capital expenditures | $13.0M | $12.0M | $1.0M | +8% |
Questions
How much did RXO's revenue grow quarter over quarter in Q3 2026?
RXO's revenue rose $97.0M (+5%) from $1.8B in Q2 2026 to $1.9B in Q3 2026. Operating margin 0.9% against 0.1% (+0.9 pts).